ArticleBreast cancer research : BCR2026

Tumor heterogeneity index from DCE-MRI for AKT-inhibition responder identification and reveals hot immune microenvironment for patients with breast cancer: a multi-omics analysis of I-SPY2 trial.

Xinzhi Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.